Evidence map›Paper›PMID 42286237›Full record

ArticleNature chemistry2026

Copper-catalysed site-selective arylation of pyrazoles.

Minghao Wang, Xintong Hou, Stephanie A Corio, Lori Digal, Jennifer S Hirschi, Vy M Dong

Abstract read
In one paragraph

Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Minghao WangDepartment of Chemistry, University of California, Irvine, Irvine, CA, USA.ORCID http://orcid.org/0009-0001-2171-3873
Xintong Hou *Department of Chemistry, University of California, Irvine, Irvine, CA, USA.
Stephanie A Corio *Department of Chemistry, Binghamton University, Binghamton, NY, USA.
Lori DigalDepartment of Chemistry, University of California, Irvine, Irvine, CA, USA.
Jennifer S HirschiDepartment of Chemistry, Binghamton University, Binghamton, NY, USA. jhirschi@binghamton.edu.ORCID http://orcid.org/0000-0002-3470-0561
Vy M DongDepartment of Chemistry, University of California, Irvine, Irvine, CA, USA. dongv@uci.edu.ORCID http://orcid.org/0000-0002-8099-1048

Funding

Innovative Tools for Chemical Synthesis: Metal-Hydride Catalysis, Medicinal Motifs, and Molecular ProbesR35GM127071 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Vy M Dong · 2018 to 2026
$4.9M
Mechanistic Investigation into Modern Catalytic ReactionsR35GM147183 · NIGMS · STATE UNIVERSITY OF NY,BINGHAMTON · PI Jennifer Hirschi · 2022 to 2026
$1.7M
National Science Foundation (NSF) CHE-180061National Science Foundation (NSF) CHE-1956457NIGMS NIH HHS R35 GM127071NIGMS NIH HHS R35 GM147183U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM127071U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM147183
6 · The paper itself

Abstract

A major challenge in late-stage functionalization is the selective N-arylation of unsymmetric pyrazoles, five-membered heterocycles with two adjacent nitrogen atoms, which are prevalent in blockbuster medicines and bioactive molecules. Traditional cross-coupling methods usually favour one type of regioisomer, limiting access to complementary structures that could accelerate drug discovery and streamline structure-activity relationship studies. Here we show that copper catalysis harnesses arynes to achieve switchable arylation of pyrazoles under mild conditions. By tuning Cu-pyrazole coordination, we direct arylation to either nitrogen atom, unlocking selectivity between two similar sites. Mechanistic studies reveal how steric and electronic effects govern regioselectivity, transforming an inherently unpredictable process into a blueprint for selective recognition of N-N linkages. This approach establishes a general strategy for controlling site selectivity in nitrogen-rich heterocycles and highlights the use of strained intermediates in late-stage diversification.

Identifiers

PMID42286237
PMCPMC13423811

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.